ABOUT US OUR FOCUS OUR PRODUCTS SCIENCE FUNDING PROGRAMS NEWSROOM INVESTORS Our Leadership Our company is led by a passionate team of professionals with deep experience in the pharmaceutical industry and a proven track record of success in developing and commercializing novel treatments for patients. JOHN C. JACOBS, MBA President and Chief Executive Officer Read Bio CATE MCCANLESS Corporate Affairs and Public Policy Read Bio JEFFREY M. DAYNO, M.D. Chief Medical Officer Read Bio SANDIP KAPADIA, CPA, MBA Chief Financial Officer Read Bio TRICIA GLOVER Chief Compliance Officer Read Bio CHRISTIAN ULRICH General Counsel Read Bio ANDREW SERAFIN, JD, MBA Chief Strategy Officer Read Bio NANCY LEONE Corporate Communications Read Bio JEFFREY DIERKS, MBA Chief Commercial Officer Read Bio DAVID BRADSHAW Technical Operations Read Bio AUDREY MURPHY Human Resources Read Bio DAVID KNOUFT Market Access and Field Commercial Read Bio SHARON GOLDBACH Facilities Operations and Executive Administration Read Bio Board of Directors Jeff Aronin Harmony Founder and Chairman, Paragon Chairman and CEO Read Bio Antonio Gracias Managing Partner/ Chief Investment Officer Valor Equity Mark Graf Private Investor Former Chief Financial Officer Discover Financial Services John Jacobs CEO Harmony Biosciences Jack Nielsen Managing Director Vivo Capital Fund VIII, L.P./ Vivo Capital Surplus Fund VIII, L.P. Juan Sabater Partner Valor Equity Gary Sender Former Chief Financial Officer, Nabriva plc Independent Board Member & Consultant Linda Szyper Former Chief Operating Officer McCann Health Dr. Andreas Wicki CEO HBM Healthcare Investments (Cayman) Ltd Harmony Biosciences 630 W. Germantown Pike, Suite 215 Plymouth Meeting, PA 19462 HarmonyBiosciences.com Harmony Biosciences name and logo are registered trademarks. ©2021 Harmony Biosciences. All Rights Reserved. US-HAR-2100055/Oct 2021 ABOUT US LEADERSHIP CULTURE ETHICS/COMPLIANCE FUNDING PROGRAMS CONTACT US PRIVACY POLICY TERMS OF USE OUR FOCUS ABOUT NARCOLEPSY SCIENCE ADVANCING THE SCIENCE SAFETY DATA SHEET NEWSROOM PRESS RELEASES INVESTORS SOCIAL MEDIA LINKEDIN TWITTER COMMUNITY GUIDELINES SITEMAP By continuing to browse this website, you are agreeing to accept our use of cookies, To learn more about our Privacy policy, click here. X